Considering what we're going to have to put on the table in the first place in order to attain that offer.
Once the data (which takes a long time to acquire) is available, then mgmt will know what we're worth. So will BP.
7+ b shares is irrelevant.
Look at that post I provided last week regarding Novo Nordisk's $200b increase in 12 months based on the popularity of their weight loss drug Ozempic.
You simply don't understand the potential of the products we're working on. Especially CF33. 50% of the global population is at risk of cancer. That's more than Oprah's desire to lose a couple of kg
IMU is all or nothing. IMO there is no other option.
IMU Price at posting:
10.0¢ Sentiment: Buy Disclosure: Held
